Which antipsychotic is licensed to manage non-cognitive symptoms of dementia?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

Which antipsychotic is licensed to manage non-cognitive symptoms of dementia?

Explanation:
Non-cognitive symptoms of dementia (like agitation, aggression, and psychosis) are sometimes treated with antipsychotics, but licensing matters. Haloperidol is the antipsychotic that has regulatory approval for managing these dementia-related behavioral symptoms in many regions, typically for short-term use when symptoms are severe or pose safety concerns. The other antipsychotics listed are not generally licensed for this indication, though they may be used off-label in some places. So, the best answer reflects the approved option for this specific use. Use the lowest effective dose for the shortest duration and monitor closely for extrapyramidal symptoms, sedation, falls, and QT prolongation, while prioritizing nonpharmacologic approaches.

Non-cognitive symptoms of dementia (like agitation, aggression, and psychosis) are sometimes treated with antipsychotics, but licensing matters. Haloperidol is the antipsychotic that has regulatory approval for managing these dementia-related behavioral symptoms in many regions, typically for short-term use when symptoms are severe or pose safety concerns. The other antipsychotics listed are not generally licensed for this indication, though they may be used off-label in some places. So, the best answer reflects the approved option for this specific use. Use the lowest effective dose for the shortest duration and monitor closely for extrapyramidal symptoms, sedation, falls, and QT prolongation, while prioritizing nonpharmacologic approaches.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy